Company Overview

Company name: Phytopharma International
Description: Manufacturer of cannabis-based products intended to offer effective healing through natural medicines made of cannabis. The company’s cannabis-based products are non-infused, highly bio-avaliable cannabis-derived containing up to 1,000 times lower measurable concentration of cannabinoids, compared to common treatment methods, enabling nutraceutical and pharmaceutical companies to produce more natural products by unlocking the full potential of medical herbs and plants.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Afula
Country: Israel
Region: Middle East

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company reached a definitive agreement to acquire Top Strike Resources (TSX: TSR.H) through a reverse merger, resulting in the combined entity trading on the TSX Venture Exchange on February 1, 2017. Subsequently the deal was cancelled.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: